journal article·2018-04

Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy

Ruirui Zhao, Guirong Zheng, Lulu Fan, Zhichun Shen, Kai Jiang, Yan Guo, Jing-Wei Shao

Acta Biomaterialia· Volume 70
Publisher page

Abstract

Nanosized drug delivery systems (NDDS) with photothermal therapy (PTT) and photodynamic therapy (PDT) have been extensively exploited to improve the therapeutic performance and bio-safety of chemotherapeutic drugs in cancer. In this work, a carrier-free nanodrug was developed by co-assembly of the anti-cancer agent ursolic acid (UA), an asialoglycoprotein receptor (ASGPR), which can recognize the target molecule lactobionic acid (LA), and the near-infrared (NIR) probe dye indocyanine green (ICG) to form UA-LA-ICG NPs by a simple and green self-assembly approach. The UA-LA-ICG NPs had suitable stability, showed controlled release profile of UA drugs, and exhibited preferable temperature response (∼59.4 °C) under laser irradiation (808 nm, 1 W/cm2). Compared with free ICG, the UA-LA-ICG NPs significantly enhanced the intracellular ICG uptake. Upon irradiation of the NIR laser, co-assembled nanodrugs demonstrated great performance as a reactive oxygen species (ROS) producer and exhibited more anti-proliferative activities on ASGPR-overexpressing HepG2 cells than ASGPR low-expressing HeLa cells. Meanwhile, in vivo NIR fluorescence imaging exhibited that the co-assembled nanodrugs were specifically targeted to the tumor by the active targeting property of LA, and its circulation time was much longer than that of free ICG. In addition, UA-LA-ICG NPs + NIR irradiation treatment displayed enhanced inhibitory effect on tumor growth in H22 tumor-bearing mice. Overall, the co-assembly of chemotherapeutic agent and photosensitizer by the self-assembly approach might open an alternative avenue and give inspiration to fabricate new carrier-free nanodrugs for cancer imaging and chemo-photo combination therapy. Statement of significance The present study for the first time reported carrier-free nanoparticles (NPs) by co-assembly of a natural product ursolic acid (UA), an asialoglycoprotein receptor (ASGPR)-recognized sugar molecule lactobionic acid (LA), and the near-infrared dye indocyanine green (ICG) through a simple and green approach. The preparation process of nanodrugs is simple, rapid, effective, and labor-saving. The co-assembled nanodrugs were capable of stabilizing the ICG molecules and specifically targeting to the tumor, which could increase the tumor accumulation in cancer imaging and also enhance the efficacy of chemo-phototherapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
2. Therapeutic nanoparticles for drug delivery in cancer10.1158/1078-0432.CCR-07-1441 ↗
3. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis10.1164/rccm.200504-613PP ↗
4. Indocyanine green loaded magnetic carbon nanoparticles for near infrared fluorescence/magnetic resonance dual-modal imaging and photothermal therapy of tumor10.1021/acsami.7b00490 ↗
5. Multifunctional photosensitizer grafted on polyethylene glycol and polyethylenimine dual-functionalized nanographene oxide for cancer-targeted near-infrared imaging and synergistic phototherapy10.1021/acsami.6b05383 ↗
6. Imaging-guided and light-triggered chemo-/photodynamic/photothermal therapy based on Gd (III) chelated mesoporous silica hybrid spheres10.1021/acsbiomaterials.6b00462 ↗
7. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer10.1021/bc300442d ↗
8. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy10.1021/nn5062386 ↗
9. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study10.1021/bm400839b ↗
10. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy10.1016/j.biomaterials.2013.04.066 ↗
11. Targeted imaging and chemo-phototherapy of brain cancer by a multifunctional drug delivery system10.1002/mabi.201500091 ↗
12. Single-step assembly of DOX/ICG loaded lipid–polymer nanoparticles for highly effective chemo-photothermal combination therapy10.1021/nn400334y ↗
13. Applications and potential toxicity of magnetic iron oxide nanoparticles10.1002/smll.201201531 ↗
14. Combination antitumor therapy with targeted dual-nanomedicines10.1016/j.addr.2017.03.001 ↗
15. Nanodrug formed by coassembly of dual anticancer drugs to inhibit cancer cell drug resistance10.1021/acsami.5b05347 ↗
16. A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic10.1038/srep36614 ↗
17. Carrier-free, chemophotodynamic dual nanodrugs via self-assembly for synergistic antitumor therapy10.1021/acsami.6b02416 ↗
18. Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview
19. Ursolic acid isolated from Eucalyptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes10.1002/(SICI)1099-1573(200005)14:3<163::AID-PTR588>3.0.CO;2-D ↗
20. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies10.1016/j.bcp.2013.03.006 ↗
21. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents10.2174/1389557033487917 ↗
22. Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes10.1016/j.jep.2008.09.001 ↗
23. Anti-diabetic potential of ursolic acid stearoyl glucoside: a new triterpenic gycosidic ester from Lantana camara10.1016/j.fitote.2011.10.004 ↗
24. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-kappaB, AP-1 and NF-AT10.1371/journal.pone.0031318 ↗
25. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer10.1016/j.ejps.2016.10.019 ↗
26. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: in vitro drug release and in vivo pharmacokinetics assessment10.1016/j.jcis.2016.11.089 ↗
27. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways10.1039/C7NR01677H ↗
28. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex10.1016/j.biomaterials.2017.07.030 ↗
29. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting10.1016/S0378-5173(03)00082-6 ↗
30. Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma10.3109/10717544.2014.907373 ↗
31. Targeted doxorubicin delivery to hepatocarcinoma cells by lactobionic acid-modified laponite nanodisks10.1039/C4NJ01916D ↗
32. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy10.1021/mp100301t ↗
33. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging10.1016/j.biomaterials.2012.04.044 ↗
34. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy10.1016/j.biomaterials.2012.01.035 ↗
35. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy10.1016/j.jconrel.2017.05.011 ↗
36. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes10.1016/j.msec.2015.04.022 ↗
37. Ursolic acid liposomes with chitosan modification: promising antitumor drug delivery and efficacy10.1016/j.msec.2016.11.014 ↗
38. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma10.1016/j.bcp.2014.11.014 ↗
39. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis10.1038/srep05006 ↗
40. Discovery of FZU-03,010 as a self-assembling anticancer amphiphile for acute myeloid leukemia10.1016/j.bmcl.2016.12.071 ↗
41. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress10.1016/S1359-6446(03)02988-X ↗
42. The 'right' size in nanobiotechnology10.1038/nbt872 ↗
43. Targeting liposomes toward novel pediatric anticancer therapeutics10.1203/PDR.0b013e3181d601c5 ↗
44. Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy10.1002/anie.201509810 ↗
45. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance10.1016/j.jconrel.2008.04.024 ↗
46. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes10.1016/j.biomaterials.2006.09.014 ↗
47. Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma10.1021/am500761x ↗
48. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications10.1016/j.jconrel.2014.12.030 ↗
49. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy10.1073/pnas.1011368107 ↗
50. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo10.1039/C7NR03129G ↗
51. Multifunctional polymeric micelles loaded with doxorubicin and poly (dithienyl-diketopyrrolopyrrole) for near-infrared light-controlled chemo-phototherapy of cancer cells10.1016/j.colsurfb.2017.05.080 ↗
52. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer10.1021/acsami.5b10426 ↗
53. A carrier-free dual-drug nanodelivery system functionalized with aptamer specific targeting HER2-overexpressing cancer cells10.1039/C7TB02562A ↗
54. Carrier-free, functionalized drug nanoparticles for targeted drug delivery10.1039/c2cc33214k ↗
55. Asialoglycoprotein receptor mediated hepatocyte targeting – Strategies and applications10.1016/j.jconrel.2015.02.022 ↗
56. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies10.1016/j.jconrel.2005.09.001 ↗
57. Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier10.1016/S0168-3659(01)00448-5 ↗
58. Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo10.1002/jbm.b.31873 ↗
59. Indocyanine green-loaded silver nanoparticle@polyaniline core/Shell theranostic nanocomposites for photoacoustic/near-infrared fluorescence imaging-guided and single-light-triggered photothermal and photodynamic therapy10.1021/acsami.6b11262 ↗
60. Robust ICG theranostic nanoparticles for folate targeted cancer imaging and highly effective photothermal therapy10.1021/am5004393 ↗
61. Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection10.1021/mp200526m ↗
62. A sweet polydopamine nanoplatform for synergistic combination of targeted chemo-photothermal therapy10.1002/marc.201500090 ↗
63. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy10.1016/j.actbio.2016.11.035 ↗